U.S. travel warning adds to pressure on Tanzania over suspected Ebola cases
DAR ES SALAAM (Reuters) – The United States has warned its citizens to take extra care when visiting Tanzania amid concerns over Ebola, adding to calls for the East African…
CVS suspends sales of Zantac brand and generic heartburn drug during safety review
People walk by a CVS Pharmacy store in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton (Reuters) – CVS Health Corp said on…
Big companies commit to slash emissions ahead of U.N. climate summit
UNITED NATIONS (Reuters) – Almost 90 big companies in sectors from food to cement to telecommunications are pledging to slash their greenhouse gas emissions in a new campaign to steer…
U.S. stock exchange competition to heat up in 2020 with new entrants
NEW YORK (Reuters) – At least three new U.S. stock exchanges are expected in 2020, executives from the companies said on Thursday, potentially lowering trading costs as the upstarts try…
Fed Chair Powell repeats vow to act ‘as appropriate’
ZURICH (Reuters) – The U.S. Federal Reserve will continue to act “as appropriate” to sustain the economic expansion in the world’s biggest economy, Fed Chair Jerome Powell said Friday in…
Novartis wins FDA’s breakthrough tag for lung cancer hopeful
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Novartis has…
Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’
(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect” in some patients because it can reverse late-stage cancer that…
Drugmakers file second court challenge to Canada’s new drug price rules
TORONTO (Reuters) – Canada’s main pharmaceutical industry lobby group, along with 16 of its member companies, filed a lawsuit on Friday to block new regulations meant to lower patented drug…
Cigna rolls out new plan to fully cover multi-million dollar gene therapies
A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid (Reuters) – Health…
Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
ZURICH (Reuters) – Swiss drugmakers Novartis and Lonza separately deepened their push into so-called biosimilars, betting cheaper copies of name-brand drugs will make headway among cost-conscious insurers and governments. Novartis’s…